BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2968376)

  • 1. Peripheral edema and oral acyclovir.
    Hisler BM; Daneshvar SA; Aronson PJ; Hashimoto K
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1142-3. PubMed ID: 2968376
    [No Abstract]   [Full Text] [Related]  

  • 2. Which term should be used to describe drug eruptions confined to sites of previous herpes zoster lesions, 'isotopic response' or 'recall phenomenon'?
    Mizukawa Y; Shiohara T
    Clin Exp Dermatol; 2004 May; 29(3):323; author reply 324. PubMed ID: 15115529
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug eruption secondary to aciclovir with recall phenomenon in a dermatome previously affected by herpes zoster.
    Carrasco L; Pastor MA; Izquierdo MJ; Fariña MC; Martín L; Fortes J; Requena L
    Clin Exp Dermatol; 2002 Mar; 27(2):132-4. PubMed ID: 11952706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trough plasma acyclovir concentrations and safety of oral acyclovir, 800 mg five times daily for 7 days in elderly patients with herpes zoster.
    Wood MJ; McKendrick MW; Freris MW; Jeal SC; Jones DA; Gilbert AM
    J Antimicrob Chemother; 1994 Jun; 33(6):1245-9. PubMed ID: 7928819
    [No Abstract]   [Full Text] [Related]  

  • 5. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral acyclovir for herpes zoster.
    Drug Ther Bull; 1988 Nov; 26(24):93-4. PubMed ID: 3060343
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous adverse reactions to acyclovir: case reports.
    Robinson GE; Weber J; Griffiths C; Underhill GS; Jeffries DJ; Goldmeir D
    Genitourin Med; 1985 Feb; 61(1):62-3. PubMed ID: 2935482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir-induced bullous reaction in a patient with metastatic breast cancer.
    Yorulmaz A; Sahin EB; Sener M; Kulcu Cakmak S
    Cutan Ocul Toxicol; 2017 Mar; 36(1):85-87. PubMed ID: 26911608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric toxicity in a patient undergoing hemodialysis and receiving treatment with oral acyclovir.
    Collins A; Krieff D; Smith C; Singer C
    Clin Infect Dis; 1996 Jan; 22(1):187-8. PubMed ID: 8825003
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute renal failure induced by oral acyclovir.
    Hernandez E; Praga M; Moreno F; Montoyo C
    Clin Nephrol; 1991 Sep; 36(3):155-6. PubMed ID: 1934676
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotoxicity associated with oral acyclovir in patients undergoing dialysis.
    MacDiarmaid-Gordon AR; O'Connor M; Beaman M; Ackrill P
    Nephron; 1992; 62(3):280-3. PubMed ID: 1436338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic contact dermatitis from acyclovir.
    Goday J; Aguirre A; Ibarra NG; Eizaguirre X
    Contact Dermatitis; 1991 May; 24(5):380-1. PubMed ID: 1832623
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal failure and coma after a high dose of oral acyclovir.
    Eck P; Silver SM; Clark EC
    N Engl J Med; 1991 Oct; 325(16):1178-9. PubMed ID: 1891032
    [No Abstract]   [Full Text] [Related]  

  • 14. Generalized maculopapular and vesicular rash.
    Wollert E; Tronnier M; Kempf W; Mitteldorf C
    J Dtsch Dermatol Ges; 2018 Feb; 16(2):234-237. PubMed ID: 29418085
    [No Abstract]   [Full Text] [Related]  

  • 15. A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster.
    Moss PJ; Wood MJ; Crooks RJ; Gallagher J; McKendrick MW
    J Antimicrob Chemother; 1995 Jul; 36(1):271-3. PubMed ID: 8537281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe central nervous system symptoms following oral administration of acyclovir in a patient with chronic renal failure: a case report].
    Niibori D; Fujisawa M; Matsuzaki M
    Hinyokika Kiyo; 1993 May; 39(5):459-61. PubMed ID: 8322628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster oticus: treatment with intravenous acyclovir.
    Dickins JR; Smith JT; Graham SS
    Laryngoscope; 1988 Jul; 98(7):776-9. PubMed ID: 3386386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact allergy to acyclovir.
    Valsecchi R; Imberti G; Cainelli T
    Contact Dermatitis; 1990 Nov; 23(5):372-3. PubMed ID: 2151378
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study Group.
    Söltz-Szöts J; Tyring S; Andersen PL; Lucht RF; McKendrick MW; Diaz Perez JL; Shukla S; Fiddian AP
    J Antimicrob Chemother; 1998 May; 41(5):549-56. PubMed ID: 9630408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.